OGI stock closed at $1.50 on January 31, 2025, down 3.23% during regular trading but gained 6.63% post-market, reaching $1.5994. Despite a challenging cannabis market, OrganiGram's strong financial performance, including a 55% adjusted EBITDA growth and international expansion, supports its resilience. However, the bearish view stems from the slowing Canadian cannabis market (4% growth expected in 2025) and increased competition, which could pressure margins and limit upside potential.